Beijing Stock Exchange 50 Index Hits 10-Month Low! Three Major Sectors See Significant Pullbacks, These Stocks Face Margin Client Selling Pressure

What are the common characteristics of individual stocks reduced by financing investors?

Cailian Press, March 17th (Editor: Zilong) Today (March 17th), the Beijing Stock Exchange 50 Index was adjusted again, reaching a nearly 10-month low since June 2025. Currently, the Beijing Stock Exchange 50 Index has experienced four consecutive declines, with the year-to-date decline expanding by nearly 5.2%.

Note: Recent continuous decline of the Beijing Stock Exchange 50 Index (as of March 17th close)

Component stocks review for the year, with significant pullbacks in these sectors

Looking at the components of the Beijing Stock Exchange 50, the 50 stocks have an average decline of 4.15% this year, with a median decline of 5.50%. Among them, 18 stocks have fallen more than 10% year-to-date, including Kote Shares, Fengguang Precision, Jinbo Biotech, Junchuang Technology, Dingzhi Technology, and Wanda Bearings, with six stocks dropping over 20%. Among the major weighted components, Jinbo Biotech has experienced a notable decline of 22%, while Betterui and Development Technology have fallen 7.4% and 6.2%, respectively.

Note: Performance of top market cap components of the Beijing Stock Exchange 50 this year (as of March 17th close)

By industry sector (Shenwan Level 1), excluding sectors with only one stock, the non-ferrous metals, electrical equipment, and basic chemicals sectors have performed relatively well, with gains of 4.8%, 4.5%, and 2.5%, respectively. Conversely, stocks from the automotive, machinery, and electronics sectors have performed poorly this year. Additionally, stocks in construction decoration, communications, computers, and biomedicine have all experienced an average decline.

Note: Average year-to-date percentage change of Beijing Stock Exchange 50 components by industry (as of March 17th close)

Looking at the overall market performance on the Beijing Stock Exchange this year, excluding the 11 newly listed stocks, the remaining nearly 290 stocks have an average decline of 3.4%, with a median decline of 5.3%, slightly outperforming the Beijing Stock Exchange 50 components. Notably, Jinhui Medical, Jiahe Technology, and Henghe Shares have fallen over 30%. Meanwhile, stocks like Keli Shares, Yinneng Power, Liancheng CNC, Liquan Technology, and Zhongcheng Technology have defied the trend and gained this year, with Keli Shares and Yinneng Power being the only two stocks on the exchange to double in value this year.

Trading volume hits new lows this year; analysis of financing trends

From the volume data, the trading volume of the Beijing Stock Exchange has been continuously declining recently, with yesterday and today recording 14.781 billion yuan and 16.865 billion yuan, respectively—both the lowest and fifth-lowest of the year. Throughout the year, the exchange has had five trading days with trading volumes below 17 billion yuan, including February 24th (163.79 billion yuan), February 13th (164.37 billion yuan), and February 11th (165.50 billion yuan).

Note: Recent changes in trading volume of the Beijing Stock Exchange (as of March 17th close)

In terms of capital, the financing balance on the Beijing Stock Exchange has shown a trend of rising and then falling this year. As of March 16th, the total financing balance was nearly 8.443 billion yuan, an increase of about 480 million yuan from the end of last year, a growth of nearly 6.1%. Notably, on January 12th, the exchange saw a record single-day net purchase of nearly 470 million yuan from financing investors, the highest this year. Conversely, on February 13th, March 2nd, and January 16th, the exchange experienced relatively high single-day net sales.

Note: Recent changes in financing balance on the Beijing Stock Exchange (as of March 16th)

Regarding individual stocks, as of March 16th, a total of 16 stocks had a net financing purchase amount exceeding 20 million yuan this year, with Liancheng CNC surpassing 100 million yuan. Stocks like Paralleling Technology, Kaide Quartz, and Keli Shares also saw significant financing inflows, while Jinbo Biotech, Betterui, Tongli Shares, Deyuan Pharmaceuticals, and Jiao Da Iron and Steel experienced significant reductions. In terms of financing control ratios, Haidar has the highest at over 7%, with Audiwei, Kaide Quartz, and Litong Technology also ranking high.

(Cailian Press, Zilong)